Abstract
Ornithine transcarbamylase (OTC) deficiency, the most common inborn error of the urea cycle, shows an X-linked inheritance with frequent new mutations. Investigations of patients with OTC deficiency have indicated an overproportionate share of mutations at CpG dinucleotides. These statistics may, however, be biased because of the easy detection of CpG mutations by screening for TaqI and MspI restriction sites. In the present study, we investigated 30 patients, with diagnosed OTC deficiency, for new sites with an increased probability of mutation by complete DNA sequence analysis of all ten exons of the OTC gene. In six patients, two codons in exons 2 and 5, respectively, contained novel recurrent mutations, all of them affecting CpG dinucleotides. They included C to T and G to A transitions in codon 40, changing an arginine to cysteine and histidine, respectively, and a C to T transition in codon 178 causing the substitution of threonine by methionine. The first two mutations were characterized by a mild clinical course with high risk of sudden death in late childhood or early adulthood, whereas the third mutation showed a more severe phenotypic expression. In addition to these novel mutations, we identified four patients with the known R277W mutation, making it the most common point mutation of the OTC gene.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barker D, Schafer M, White R (1984) Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 36: 131–138
Brusilow SW, Horwich AL (1989) Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 629–663
Feldman D, Rozet JM, Pelet A, Hentzen D, Briand P, Hubert P, Largilliere C, Rabier D, Farriaux JP, Munnich A (1992) Site-specific screening for point mutations in ornithine transcarbamylase deficiency. J Med Genet 29: 471–475
Finkelstein JE, Francomano CA, Brusilow SW, Traystman MD (1990) Use of denaturing gradient gel electrophoresesis for detection of mutation and prospective diagnosis in late onset ornithine transcarbamylase deficiency. Genomics 7: 167–172
Grompe M, Caskey CT, Fenwick RG (1991) Improved molecular diagnostics for ornithine transcarbamylase deficiency. Am J Hum Genet 48: 212–222
Hata A, Tsuzuki T, Shimada K, Takiguchi M, Mori M, Matsuda I (1988) Structure of the human ornithine transcarbamylase gene. J Biochem 103: 302–308
Hata A, Setoyama C, Shimada K, Takeda E, Kuroda Y, Akaboshi I, Matsuda I (1989) Ornithine transcarbamylase deficiency resulting from a C-to-T substitution in exon 5 of the ornithine transcarbamylase gene. Am J Hum Genet 45: 123–127
Hata A, Matsuura T, Setoyama C, Shimada K, Yokoi T, Akaboshi I, Matsuda I (1991) A novel missense mutation in exon 8 of the ornithine transcarbamylase gene in two unrelated male patients with mild ornithine transcarbamylase deficiency. Hum Genet 87: 28–32
Hentzen D, Pelet A, Feldmann D, Rabier D, Berthelot J, Munnich A (1991) Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene. Hum Genet 88: 153–156
Herrmann G, Frischauf A-M (1987) Isolation of genomic DNA. Methods Enzymol 152: 180–199
Horwich AL, Fenton WA, Williams KR, Kalousek F, Kraus JP, Doolittle RF, Konigsberg W, Rosenberg LE (1984) Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase. Science 224: 1068–1074
Liechti-Gallati S, Dionisi C, Bachmann C, Wermuth B, Colombo J-P (1991) Direct and in-direct mutation analysis in patients with ornithine transcarbamylase deficiency. Enzyme 45: 81–91
Maddalena A, Spence JE, O'Brien WE, Nussbaum RL (1988) Characterizations of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency. J Clin Invest 82: 1353–1358
Matsuura T, Hoshide R, Setoyama C, Shimada K, Hase Y, Yanagawa T, Kajita M, Matsuda I (1993) Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns. Hum Genet 92: 49–56
Nussbaum RL, Boggs BA, Beaudet AL, Doyle S, Potter JL, O'Brien WE (1986) New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency. Am J Hum Genet 38: 149–158
Reish O, Plante RJ, Tuchman M (1993) Four new mutations in the ornithine transcarbamylase gene. Biochem Med Metab Biol 50: 169–175
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74: 5463–5467
Spence JE, Maddalena A, O'Brien WE, Fernbach SD, Batshaw ML, Leonard CL, Beaudet AL (1989) Prenatal diagnosis and heterozygote detection by DNA analysis in ornithine transcarbamylase deficiency. J Pediatr 114: 582–588
Strautnieks S, Rutland P, Malcolm S (1991) Arginine 109 to glutamine mutation in a girl with ornithine carbamoylphosphate transferase deficiency. J Med Genet 28: 871–874
Suess PJ, Tsai MY, Holzknecht RA, Horowitz M, Tuchman M (1992) Screening for gene deletions and known mutations in 13 patients with ornithine transcarbamylase deficiency. Biochem Med Metab Biol 47: 250–259
Tuchman M, Holzknecht RA, Gueron AB, Berry SA, Tsai MY (1992) Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism. Pediatr Res 32: 600–604
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leibundgut, E.O., Liechti-Gallati, S., Colombo, JP. et al. Ornithine transcarbamylase deficiency: new sites with increased probability of mutation. Hum Genet 95, 191–196 (1995). https://doi.org/10.1007/BF00209400
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00209400